BOOKMARK
  • Korean|
  • Chinese|
  • Japanese|
  • Vietnamese
본문내용 바로가기

Aju Business Daily

SEARCH
  • ECONOMY
  • ENTERTAINMENT
  • IT
  • South Korea
  • North Korea
  • WORLD
  • SPORTS
  • LIFESTYLE
  • AUTO MOTIVE
  • OPINION
  • PEOPLE
  • MILITARY
Home > Health > article

Korea United Pharm's asthma drug candidate to be regenerated for COVID-19 treatment

Lim Chang-won Reporter(cwlim34@ajunews.com) | Posted : August 19, 2020, 15:00 | Updated : August 19, 2020, 15:00
  • 트위터
  • 페이스북
  • 웨이보

[Courtesy of Korea United Pharm ]


SEOUL -- Korea United Pharm will develop an inhaler-type treatment of COVID-19 patients by regenerating an asthma drug candidate which is easy to take without the help of medical staff and contributes to the prevention of secondary infections. Quick clinical trials will be conducted and completed in the Philippines.

The pharmaceutical company said that it would develop a COVID-19 drug by using its asthma drug candidate called UI030 which has a low risk of systemic side effects and shows both antiviral and immuno-control effects. The Ministry of Food and Drug Safety has approved a Phase 1 clinical test.

Korea United Pharm has reduced the side effects of symbicort turbuhaler, an asthma inhalation therapy that controls the symptoms of asthma and prevents asthma attacks by keeping the airways open to make breathing easier. In an in vitro cell test conducted at Korea University School of Medicine, the company said UI030's antiviral effect was up to 30 times higher than ciclesonide, a glucocorticoid used to treat asthma and allergic rhinitis.

"UI030 is expected to present a new direction for COVID-19 treatment through dual action of antiviral and immuno-control," CEO Kang Duk-young told a news conference. Rapid commercialization is possible next year because raw materials have already been developed for mass production, he said, citing UI030's safety.

  • Lim Chang-won Reporter
  • email : cwlim34@ajunews.com
© Aju Business Daily & www.ajunews.com Copyright: All materials on this site may not be reproduced, distributed, transmitted, displayed, published or broadcast without the authorization from the Aju News Corporation.
  • twitter
  • facebook
  • weibo
  • link copy
  • LIST
  • TOP

Related news

  • .Semiconductor-based fast test kit using saliva able to debut in March: science minister.
    Semiconductor-based fast test kit using saliva able to debut…
  • .Syringes for COVID-19 vaccines added to list of K-quarantine technologies.
    Syringes for COVID-19 vaccines added to list of 'K-quarantin…
  • .Health officials heave sigh of relief at early introduction of Novavax vaccine .
    Health officials heave sigh of relief at early introduction …
  • .Bukwangs COVID-19 treatment wins FDA approve to go ahead with second-phase clinical trials.
    Bukwang's COVID-19 treatment wins FDA approve to go ahead wi…
  • .Experts give conditional consent to AstraZenecas vaccine for people over 65.
    Experts give conditional consent to AstraZeneca's vaccine fo…

Real Time Photo News

  • .BTS agency posts record earnings in 2020 on brisk online activities and album sales .

    BTS agency posts record earnings in 2020 on brisk online activities and album sales

  • .[FOCUS] BTS agency leagues with Universal Music to launch new K-pop band in US music scene.

    [FOCUS] BTS agency leagues with Universal Music to launch new K-pop band in US music scene

  • .CJ ENM aims to become major visual content producer thru partnership with Epic Games .

    CJ ENM aims to become major visual content producer thru partnership with Epic Games

  • .​Solo singer Sunmi to come back with new album Tail.

    ​Solo singer Sunmi to come back with new album 'Tail'

  • .Big Hits live-streaming joint venture gains reinforcements from Universal Music, YG.

    Big Hit's live-streaming joint venture gains reinforcements from Universal Music, YG

Latest News

more+

  • Prime Minister Chung stresses importance of 'borderless communication channel' to minimize informati…
  • State hospital succeeds in inserting wireless pacemakers into hearts of bradyarrhythmia patients
  • LG Electronics' joint venture with Canada's Magna awaits approval by shareholders in March
  • Sajo Seafood to launch raw tuna menu delivery service
  • Researchers find new roundworm species near Dokdo
Aju Business Daily
  • ABOUT US
  • CONTACT US
  • PRIVACY STATEMENT
  • Copyright Policy

Address : Aju News Corporation LEEMA Building, 11th floor, 42, Jong-ro 1-gil, Jongno-gu, Seoul.    Mail : swatchsjp@ajunews.com

Copyright ⓒ 2016 By Ajunews Corporation, All Rights Reserved.

Mobile view